Prescription drug spending (or Part D) has accounted for more than 60 percent of the slowdown in Medicare benefits since 2011, according to an analysis presented in Health Affairs.

Unfortunately, “the outsized role that Part D has played in the Medicare slowdown is bad budget news because it may prove fleeting,” according to authors Loren Adler, research director for the Committee for a Responsible Federal Budget (CRFB) and Adam Rosenberg, policy analyst at CRFB.

Read more below: